The mechanism of cyclosporine-induced cholestasis in the rat.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 3388517)

Published in Transplant Proc on June 01, 1988

Authors

B Stone1, V Warty, V Dindzans, D Van Thiel

Author Affiliations

1: University of Pittsburgh, PA 15261.

Articles by these authors

(truncated to the top 100)

Liver transplantation (1). N Engl J Med (1989) 4.53

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Liver transplantation (2). N Engl J Med (1989) 2.93

The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care (1993) 2.70

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16

Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96

Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89

Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc (1988) 1.64

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61

FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc (1987) 1.56

The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A (1985) 1.51

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc (1991) 1.24

Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol (1993) 1.23

Differences in the binding, internalization and catabolism of low-density lipoprotein between normal human T and B lymphocytes. Biochem J (1985) 1.21

Liver transplantation in older patients. N Engl J Med (1987) 1.20

The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients. Transplant Proc (1985) 1.19

Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18

Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16

Effective removal of copper by plasma exchange in fulminant Wilson's disease. Transfusion (1998) 1.14

Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol (1984) 1.13

Effect of Cyclosporin-A on Hepatic and Renal Allograft Mononuclear Cell Infiltration. Transplant Proc (1983) 1.11

Cyclosporin A-induced cholestasis. The mechanism in a rat model. Gastroenterology (1987) 1.10

Fructose protects rat hepatocytes from anoxic injury. Effect on intracellular ATP, Ca2+i, Mg2+i, Na+i, and pHi. J Biol Chem (1992) 1.08

Effect of anoxia on intracellular ATP, Na+i, Ca2+i, Mg2+i, and cytotoxicity in rat hepatocytes. J Biol Chem (1992) 1.06

Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc (1991) 1.06

Quality of life before and after orthotopic hepatic transplantation. Arch Intern Med (1991) 1.03

Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02

Indocyanine green elimination test in orthotopic liver recipients. Hepatology (1996) 0.96

Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc (1991) 0.93

Reversible activation-inactivation of cholesterol 7alpha-hydroxylase possibly due to phosphorylation-dephosphorylation. Biochem Biophys Res Commun (1981) 0.92

The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation (1992) 0.91

Comparison of methods for analyzing gastric isotope emptying. Am J Physiol (1982) 0.90

FK506 and pregnancy in liver transplant patients. Transplantation (1993) 0.90

Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology (1995) 0.90

Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation. Does the etiology of cirrhosis make a difference? Dig Dis Sci (1990) 0.88

Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic liver disease. Alcohol Clin Exp Res (1983) 0.87

Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc (1992) 0.87

Fluconazole therapy in transplant recipients receiving FK506. Transplantation (1994) 0.86

A consensus conference on complex biologics and low molecular weight heparins. Int Angiol (2010) 0.86

An international study of the relationship between alcohol consumption and postmenopausal estradiol levels. Alcohol Alcohol Suppl (1991) 0.85

FK 506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc (1991) 0.85

Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc (1991) 0.85

Effects of acute exercise on high density lipoprotein cholesterol and high density lipoprotein subfractions in moderately trained females. Br J Sports Med (1998) 0.84

Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation (1995) 0.84

Plasma amino acids in liver transplantation: correlation with clinical outcome. Surgery (1985) 0.84

Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology (1987) 0.84

Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A resolution. Nat Struct Biol (1994) 0.84

Effects of exercise with varying energy expenditure on high-density lipoprotein-cholesterol. Eur J Appl Physiol Occup Physiol (1996) 0.84

Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc (1987) 0.83

On the differential suppression of cholesterol synthesis by low density lipoprotein in B and T lymphocytes. Biochim Biophys Acta (1981) 0.83

Gallbladder function in diabetic patients. J Nucl Med (1986) 0.83

Enterocutaneous fistula: a rare complication of PEG tube placement. Gastrointest Endosc (2001) 0.82

Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. Transplantation (1994) 0.82

ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells. J Surg Res (1996) 0.82

Liver transplantation. Initial experience in the Veterans Administration. Dig Dis Sci (1990) 0.82

Association of retinol binding protein in multiple-case families with insulin-dependent diabetes. Hum Biol (1997) 0.81

Association of HLA Compatibility and Decreased Liver Transplant Survival. Transplant Proc (1988) 0.81

Cyclosporine augments hepatic regenerative response in rats. Dig Dis Sci (1990) 0.81

Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant (1995) 0.81

The acute effects of exercise intensity on HDL-C metabolism. Med Sci Sports Exerc (1994) 0.81

Orthotopic liver transplantation for fulminant and subacute hepatic failure. Gastroenterol Clin North Am (1988) 0.81

Lymphocyte cholesterol synthesis in chronic lymphocytic leukemia. Life Sci (1982) 0.80

Differential suppression of lymphocyte cholesterol synthesis by low density lipoprotein and erythrocyte insulin receptors in normolipidemic subjects. Atherosclerosis (1983) 0.80

Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology (1993) 0.80

Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. Liver Transpl Surg (1998) 0.80

Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Am J Clin Nutr (1990) 0.80

Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc (1991) 0.79

Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals. Transplant Proc (1987) 0.79

Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc (1992) 0.78

Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc (1992) 0.78

Transmission of HCV by organ transplantation. N Engl J Med (1992) 0.78

A selective defect in secretion of alpha 1-proteinase inhibitor PiZZ demonstrated in surrogate and primary extrahepatic cell culture. Trans Assoc Am Physicians (1985) 0.78

Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. Transplantation (1992) 0.78

Brain morphologic characteristics of cirrhotic alcoholics and cirrhotic nonalcoholics: an MRI study. Alcohol Clin Exp Res (1992) 0.78

FK506 enhances fibrogenesis in in vitro and in vivo models of liver fibrosis in rats. Gastroenterology (1994) 0.78

Hepatic, nutritional, and genetic influences on cognitive process in alcoholics. NIDA Res Monogr (1990) 0.78

Endoscopic findings in alcoholic liver disease: does gender make a difference? Alcohol (1990) 0.77

Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma. J Viral Hepat (1997) 0.77

Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption. Arterioscler Thromb (1992) 0.77

Gallbladder function: methods for measuring filling and emptying. J Nucl Med (1985) 0.77

Alcohol, coronary heart disease, and total mortality. Recent Dev Alcohol (1985) 0.77

Comparison of exercise and normal variability on HDL cholesterol concentrations and lipolytic activity. Int J Sports Med (1996) 0.77

Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. Transplant Proc (1991) 0.76

Discordance between glucokinase activity and insulin and glucagon receptor changes occurring during liver regeneration in the rat. Horm Metab Res (1984) 0.76

EktaChem assay for phosphorus evaluated. Clin Chem (1985) 0.76

Fasting enhances the effects of anoxia on ATP, Cai2+ and cell injury in isolated rat hepatocytes. Biochim Biophys Acta (1993) 0.76

Splenic artery aneurysms occurring in liver transplant recipients. Transplantation (1991) 0.76

Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice. Adv Exp Med Biol (1987) 0.76

Blood protein binding of cyclosporine in transplant patients. J Clin Pharmacol (1987) 0.75

WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation. Hosp Rec Study (1988) 0.75

Effect of renal ischemia on plasma levels of FK 506 in rats. Transplant Proc (1992) 0.75

Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc (1992) 0.75